Genes, proteins, and neurotoxins involved in Parkinson's disease

被引:141
作者
von Bohlen und Halbach, O
Schober, A
Krieglstein, K
机构
[1] Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany
[2] Univ Gottingen, Dept Neuroanat, D-37075 Gottingen, Germany
[3] Univ Gottingen, Dept Neuroanat, CMPB, D-37075 Gottingen, Germany
关键词
D O I
10.1016/j.pneurobio.2004.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder. The etiology of PD is likely due to combinations of environmental and genetic factors. In addition to the loss of neurons, including dopaminergic neurons in the substantia nigra pars compacta, a further morphologic hallmark of PD is the presence of Lewy bodies and Lewy neurites. The formation of these proteinaceous inclusions involves interaction of several proteins, including alpha-synuclein, synphilin-1, parkin and UCH-L1. Animal models allow to get insight into the mechanisms of several symptoms of PD, allow investigating new therapeutic strategies and, in addition, provide an indispensable tool for basic research. In animals PD does not arise spontaneously, thus, characteristic and specific functional changes have to be mimicked by application of neurotoxic agents or by genetic manipulations. In this review we will focus on genes and gene loci involved in PD, the functions of proteins involved in the formation of cytoplasmatic inclusions, their interactions, and their possible role in PD. In addition, we will review the current animal models of PD. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:151 / 177
页数:27
相关论文
共 307 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons [J].
Ahmadi, FA ;
Linseman, DA ;
Grammatopoulos, TN ;
Jones, SM ;
Bouchard, RJ ;
Freed, CR ;
Heidenreich, KA ;
Zawada, WM .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (04) :914-921
[3]   Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats [J].
Alam, M ;
Schmidt, WJ .
BEHAVIOURAL BRAIN RESEARCH, 2002, 136 (01) :317-324
[4]   Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].
Alam, ZI ;
Jenner, A ;
Daniel, SE ;
Lees, AJ ;
Cairns, N ;
Marsden, CD ;
Jenner, P ;
Halliwell, B .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203
[5]   Mapping of rat brain using the synuclein-1 monoclonal antibody reveals somatodendritic expression of α-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies [J].
Andringa, G ;
Du, F ;
Chase, TN ;
Bennett, MC .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (10) :1060-1075
[6]  
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
[7]   Pharmacological prevention of Parkinson disease in Drosophila [J].
Auluck, PK ;
Bonini, NM .
NATURE MEDICINE, 2002, 8 (11) :1185-1186
[8]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[9]   No pathogenic mutations in the synphilin-1 gene in Parkinson's disease [J].
Bandopadhyay, R ;
de Silva, R ;
Khan, N ;
Graham, E ;
Vaughan, J ;
Engelender, S ;
Ross, C ;
Morris, H ;
Morris, C ;
Wood, NW ;
Daniel, S ;
Lees, A .
NEUROSCIENCE LETTERS, 2001, 307 (02) :125-127
[10]   Adenosine A2A receptor antagonist treatment of Parkinson's disease [J].
Bara-Jimenez, W ;
Sherzai, A ;
Dimitrova, T ;
Favit, A ;
Bibbiani, F ;
Gillespie, M ;
Morris, MJ ;
Mouradian, MM ;
Chase, TN .
NEUROLOGY, 2003, 61 (03) :293-296